M. Isabel Chiu
Corporate Officer/Principal at C4 THERAPEUTICS, INC.
Network origin in M. Isabel Chiu first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 34 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to M. Isabel Chiu via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Advent International LP
Advent International LP Investment ManagersFinance Advent International LP (Advent) is an independent private equity firm founded in 1984 by Henry H. Haight. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Director/Board Member | |
BARR PHARMACEUTICALS INC | Pharmaceuticals: Generic | Chief Executive Officer Director of Finance/CFO | |
MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
DNIB UNWIND INC | Biotechnology | Chief Executive Officer | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact | |
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Investment Managers | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree | |
Stanford University | College/University | Graduate Degree Graduate Degree | |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Oridion Systems Ltd.
Oridion Systems Ltd. Medical SpecialtiesHealth Technology Oridion Systems Ltd. develops medical devices for patient safety monitoring. It produces medical devices (hardware) and patient interfaces (consumables) based on its patented Microstream and Smart Capnography technologies for the enhancement of patient safety and clinical outcomes. It provides solutions for respiratory monitoring and airway management for patients which includes non-incubated patients, premature newborns and clinical environments which includes procedural sedation, pain management, critical care units, post-anesthesia care units, emergency medical services, transport and alternate care. It operates in Jerusalem, Israel, Needham, Massachusetts and the United States of America. The company was founded by Yacov Bubis in 1987 and is headquartered in Jerusalem, Israel. | Medical Specialties | Director/Board Member | |
Boston University | College/University | Undergraduate Degree Graduate Degree | |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Yale University | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Spear Therapeutics Ltd.
Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member Founder Director/Board Member | |
Dartmouth Medical School | College/University | Graduate Degree | |
Synthesis Capital
Synthesis Capital Investment ManagersFinance Synthesis Capital is a venture capital firm founded in 2007. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Chief Executive Officer | |
AlloMek Therapeutics LLC
AlloMek Therapeutics LLC Pharmaceuticals: MajorHealth Technology AlloMek Therapeutics LLC develops and discovers pharmaceutical products for cancer therapies. It offers MEK kinase inhibitors that improve the biopharmaceutical properties of previous MEK inhibitors. The company was founded by Khire R. Uday and Barry Hart in 2010 and is headquartered in Farmington, CT. | Pharmaceuticals: Major | Director/Board Member | |
Tuck School of Business at Dartmouth | College/University | Masters Business Admin | |
SYROS PHARMACEUTICALS, INC. | Biotechnology | Public Communications Contact | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member | |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Regenacy Pharmaceuticals LLC
Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Regenacy Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It develops treatments for diabetic and peripheral neuropathies. The firm provides treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors. It provides treatment for diseases such as sickle cell disease, ß-thalassemia, leukemia, and cognitive dysfunction in neurological disorders. The company was founded by Marc A. Cohen in December 2016 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Cormorant Asset Management LLC/Private Equity/
Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management LLC/Private Equity/ (Cormorant Asset Management) is a venture capital subsidiary of Cormorant Asset Management LP founded in 2013 by Bi Hua Chen. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Synkine Therapeutics, Inc. | Chief Executive Officer | ||
Mana Therapeutics, Inc.
Mana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mana Therapeutics, Inc. provides clinical cell immune therapies that can eliminate cancer cells. The company was founded by Catherine Bollard, Patrick Hanley, C. Russell Y. Cruz and Marc Cohen and is headquartered in Arlington, VA. | Miscellaneous Commercial Services | Director/Board Member Founder Director/Board Member | |
Bublup, Inc.
Bublup, Inc. Internet Software/ServicesTechnology Services Bublup, Inc. engages in the development of a cloud platform for saving photos and documents. The company was founded on December 27, 2011 and is headquartered in Arlington, VA. | Internet Software/Services | Chief Executive Officer Chief Executive Officer | |
Raqia Therapeutics, Inc. | Chairman Director/Board Member Director/Board Member | ||
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member Founder Director/Board Member | |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member Director/Board Member |
Statistics
International
United States | 46 |
Israel | 3 |
Netherlands | 2 |
Germany | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 26 |
Consumer Services | 10 |
Finance | 6 |
Commercial Services | 6 |
Technology Services | 3 |
Operational
Director/Board Member | 146 |
Corporate Officer/Principal | 71 |
Independent Dir/Board Member | 41 |
Founder | 28 |
Chairman | 28 |
Most connected contacts
Insiders | |
---|---|
Bihua Chen | 32 |
Jason S. Fisherman | 30 |
Owen Hughes | 23 |
Andrew Phillips | 23 |
Marc A. Cohen | 21 |
William McKee | 20 |
Bruce Downey | 18 |
Kenneth Anderson | 17 |
Thomas E. Needham | 17 |
Glenn Dubin | 12 |
Donna Grogan | 12 |
Elena Prokupets | 11 |
Leonard Reyno | 10 |
Malcolm Salter | 8 |
Andrew Hirsch | 8 |
- Stock Market
- Insiders
- M. Isabel Chiu
- Company connections